Why the study?
Does left ventricular ejection fraction predict mortality better than other clinical and hemodynamic indices in patients with medically-treated coronary artery disease?
Does left ventricular ejection fraction predict mortality better than other clinical and hemodynamic indices in patients with medically-treated coronary artery disease?
Left ventricular ejection fraction is a more powerful predictor of short-term mortality than other hemodynamic, angiographic, or electrocardiographic indices in patients with medically managed coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Preserved EF may refine mortality risk stratification in 3-vessel CAD; leaves open superiority over other indices in modern cohorts.
Nelson et al. (1975) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: